Patient surface radiation doses at two pet imaging facilities

Health Physics

Volumn 84, Issue 4, 2003, Pages 451-456

  Gonzalez, L ^a   Cordeiro, C A ^a   Vano, E ^a   Perez Castejon, M J ^a,b   Jimenez, A ^a,b   Montz, H R ^b   Domper, M ^b   Carreras, J L ^a,b  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b Instituto PET Focuscan   (Spain)

Author keywords

Dose, organ; Dosimetry; Patient protection; Positron emission tomography

Indexed keywords

RADIOISOTOPE; TRACER;

ARTICLE; BREAST; CALCULATION; DOSIMETRY; FEMALE; GONAD; HEART MUSCLE; HUMAN; IMAGING; LIVER; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE; SKIN;

ADULT; BREAST; FEMALE; FLUORODEOXYGLUCOSE F18; GONADS; HEART; HUMANS; LIVER; MALE; MYOCARDIUM; ORGAN SPECIFICITY; OVARY; RADIATION DOSAGE; RADIOMETRY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SAFETY; SENSITIVITY AND SPECIFICITY; SKIN; THERMOLUMINESCENT DOSIMETRY;

EID: 0037375387     PISSN: 00179078     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004032-200304000-00004     Document Type: Article

References (14)

1. Deloar HM, Fujiwara T, Shidahara M, Nakamura T, Yamadera A, Itoh M. Internal absorbed dose estimation by a TLD method for 18F-FDG and comparison with the dose estimates from whole body PET. Phys Med Biol 44:595-606; 1999.
2. European Commission. Guidance on diagnostic reference levels for medical exposures. Radiat Protect 109; 1999.
3. European Union. Council Directive 97/43 Euratom, on health protection of individuals against the dangers of ionizing radiation in relation to medical exposure, and repealing Directive 84/466 Euratom. Official J European Communities L 180:22-27; 1997.
4. Gonzalez L, Vano E, Cordeiro CA, Carreras JL. Preliminary safety evaluation of a cyclotron facility for positron emission tomography imaging. Eur J Nucl Med 26:894-899; 1999.
5. Herzog H, Zilken H, Niederbremer A, Friedrich W, Muller-Gartner HW. Calculation of residence times and radiation doses using the standard PC software Excel. Eur J Nucl Med 24:1514-1521; 1997.
6. International Commission on Radiological Protection. Radiation dose to patients from radiopharmaceuticals. Oxford: Pergamon Press; ICRP Publication 53; Ann ICRP 18(1-4); 1988.
7. International Commission on Radiological Protection. 1990 Recommendations of the International Commission on Radiological Protection. Oxford: Pergamon Press; ICRP Publication 60; Ann ICRP 21(1-3); 1991.
8. International Commission on Radiological Protection. Radiological protection and safety in medicine. Oxford: Pergamon Press; ICRP Publication 73; Ann ICRP 26(2); 1996.
9. International Commission on Radiological Protection. Radiation dose to patients from radiopharmaceuticals. Oxford: Pergamon Press; ICRP Publication 80; Ann ICRP 28(3); 1998.
10. Johns HE, Cunningham JR. The physics of radiology. Springfield, IL: Charles C Thomas Publications; 1983.
11. Mejia AA, Nakamura T, Masatoshi I, Hatazawa J, Masaki M, Watanuki S. Estimation of absorbed dose in humans due to intravenous administration of fluorine-18-fluorodeoxyglucose in PET studies. J Nucl Med 32:699-706; 1991.
12. Ruhlman J, Oehr P, Biersack HJ. PET in oncology. Basics and clinical applications. New York: Springer Verlag; 1999.
13. Stabin MG, Stubbs JB, Toohey RE. Radiation dose estimates for radiopharmaceuticals. Oak Ridge, TN: Radiation Internal Dose Information Center, Oak Ridge Institute for Science and Education; 1996.
14. Stabin MG. Health concerns related to radiation exposure of the female nuclear medicine patient. Environmental Health Perspectives 105:1403-1409; 1997. Available at http://www.orau.gov/ehsd/ridic.htm. Accessed 1 February 2002.